| | | | | |
| $31,7800 | -0,22% | $280,50M | $32,85K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | $14,1400 | +0,57% | $280,16M | $69,46K | |
TSI TCW Strategic Income Fund, Inc. | $4,4000 | +0,46% | $279,70M | $154,26K | |
PAII Pyrophyte Acquisition Corp. II | $10,2850 | +0,15% | $279,21M | $1,64K | |
| $14,2800 | +2,00% | $279,07M | $238,03K | |
YDES YD Bio Limited Ordinary Shares | $4,6500 | -0,22% | $279,07M | $9,65K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | $10,0450 | +0,55% | $278,71M | $5,97K | |
RWAY Runway Growth Finance Corp. Common Stock | $6,5600 | -0,15% | $278,70M | $369,34K | |
JILL J.Jill, Inc. Common Stock | $19,7600 | -1,25% | $278,69M | $41,78K | |
LCTX Lineage Cell Therapeutics, Inc. | $1,1300 | +3,67% | $278,19M | $1,03M | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | $10,3150 | -0,05% | $278,12M | $154,69K | |
ACV Virtus Diversified Income & Convertible Fund | $26,5600 | +0,38% | $278,09M | $42,23K | |
ALXO ALX Oncology Holdings Inc. Common Stock | $1,9950 | +0,25% | $277,93M | $466,05K | |
| $1,4300 | +2,14% | $277,83M | $540,33K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | $2,9900 | -0,33% | $277,66M | $45,53K | |
